Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Novel(US)
United States
- Overland Park, Kansas
- 29/05/2024
- Pre Series A
- $15,000,000
Novel's fintech funding platform breaks down the traditional growth barriers faced by today’s B2B software companies. Their tech-first approach makes it easy for customers to leverage future recurring revenue for immediate access to non-dilutive capital. Paired with online data-driven insights and curated resources, the Novel platform empowers entrepreneurs to capitalize on their momentum.
- Industry Financial Services
- Website https://novelcapital.com/
- LinkedIn https://www.linkedin.com/company/novelcapital/
Related People
Carlos AntequeraCo Founder
United States -
Kansas City Metropolitan Area
Fintech CEO, early-stage investor and advisor to technology companies. Seasoned technology entrepreneur with experience managing all aspects of a fast-growing start-up: Raising angel and institutional investment, business modeling and strategy, engineering, operations, product management, marketing, customer service, finance and corporate development. I serve in technology company boards and enjoy mentoring up-and-coming entrepreneurs.
Key Areas of expertise: Revenue-Based Financing, Early Stage Investing, EdTech, Talent Management, Enterprise Software Development, Product Management, M&A, Corporate Development Strategy, Private Equity, B2B Sales and Marketing.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)